Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma

Xiaolong Tang, Longzhou Chen, Amin Li, Shiyu Cai, Yinci Zhang, Xueke Liu, Zhenyou Jiang, Xinkuang Liu, Yong Liang, Dong Ma
  • Drug Delivery, January 2018, Taylor & Francis
  • DOI: 10.1080/10717544.2018.1477859
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.1080/10717544.2018.1477859

In partnership with: